Tasmania born, schooled in Hong Kong, now working in Melbourne, scientist Nick Murphy is on the frontier of IVF reproductive medicine. Nick and his small highly skilled team developed a world-first genetic screening test for IVF embryos capable of detecting several thousand severe genetic diseases and life threatening conditions. And it’s done in one single, simple test, via whole genome sequencing of the pre-implantation embryo. It’s commercialised by Nick’s startup, GenEmbryomics. Dr Murphy will offer this test through existing IVF clinics, at as low a price as possible, and to as many couples going through IVF as need it.
While not available commercially yet in Australia, GenEmbryomics is in the process of securing patents for the test in the massive IVF market in the USA, worth some $9billion. There are plans to list the startup on New York’s NASDAQ exchange by mid-2024. It’s been a wild and fascinating journey for this genetic scientist turned entrepreneur, since the GenEmbryomics business began in 2019. Hope you enjoy Dr Nick Murphy.

Macquarie Technology Group - David Tudehope disrupts telco giant Telstra, building a phone, internet, cyber security, data centres and AI group to support business, now worth over $1.5 billion
1:06:15

OOXii Global – Dr Sarah Crowe helps more people see, with her mobile OOXii Vision Kit getting low cost, durable, prescription eye glasses to the millions who need better vision but cannot access eye glasses
1:02:01

Kantoko – Zac Altman 2.0 innovating with an ADHD telehealth service, offering professional diagnosis and care for adults, via a subscription model
1:02:30